July 11, 2012
Astellas Pharma and Maruishi Pharmaceutical announced on July 10 that they reached an agreement for the transfer of two products currently marketed by Astellas. The agreement was signed on December 1, 2011. Two active pharmaceutical ingredients (APIs) manufactured and marketed...read more